GMAB · Genmab A/S · Financials
Market Cap
$21.72B
Shares
614.90M
Volume · Sep 30
5.15M
Avg daily vol (3M)
2.39M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$3.72B
+19.2%
FY2025
Net Income
$963M
-15%
FY2025
Gross Margin
93.6%
-1.8pp
FY2025
Operating Margin
28.63%
-2.5pp
FY2025
Diluted EPS
$15.37
-12.3%
FY2025
Operating Cash Flow
$1.19B
+5.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|
| DKK | — | — | — | 661M | 342M | 214M | 147M |
| USD/shares | $15.50 | $17.66 | $9.67 | — | — | — | — |
| USD/shares | $15.37 | $17.53 | $9.58 | — | — | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.